CHAMPION Clinical Trial: Substantial reduction in 30-day readmissions in Medicare-eligible patients - Background and Rationale for Implantable Hemodynamic Monitoring - Hemodynamic Monitoring for Heart Failure Patients
![Distribution of postpartum blood loss: modeling, estimation and application to clinical trials | Reproductive Health | Full Text Distribution of postpartum blood loss: modeling, estimation and application to clinical trials | Reproductive Health | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12978-018-0641-1/MediaObjects/12978_2018_641_Fig5_HTML.png)
Distribution of postpartum blood loss: modeling, estimation and application to clinical trials | Reproductive Health | Full Text
![CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so. - ppt download CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so. - ppt download](https://slideplayer.com/slide/16381394/95/images/1/CHAMPION.jpg)
CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so. - ppt download
![CHAMPION∗ Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System - Journal of Cardiac Failure CHAMPION∗ Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System - Journal of Cardiac Failure](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2dacac5c-2d5a-4cd9-8aab-53c217ba841f/gr1.jpg)
CHAMPION∗ Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System - Journal of Cardiac Failure
CardioMEMS in a Busy Cardiology Practice: Less than Optimal Implementation of a Valuable Tool to Reduce Heart Failure Readmissions
![Maternal characteristics and causes associated with refractory postpartum haemorrhage after vaginal birth: a secondary analysis of the WHO CHAMPION trial data - Widmer - 2020 - BJOG: An International Journal of Obstetrics Maternal characteristics and causes associated with refractory postpartum haemorrhage after vaginal birth: a secondary analysis of the WHO CHAMPION trial data - Widmer - 2020 - BJOG: An International Journal of Obstetrics](https://obgyn.onlinelibrary.wiley.com/cms/asset/be23f1eb-8a07-4e0c-953a-e8ba800db65e/bjo16040-fig-0001-m.jpg)
Maternal characteristics and causes associated with refractory postpartum haemorrhage after vaginal birth: a secondary analysis of the WHO CHAMPION trial data - Widmer - 2020 - BJOG: An International Journal of Obstetrics
![IMPACT OF INTRODUCTION OF PULMONARY ARTERY PRESSURE MONITORING FOR HEART FAILURE MANAGEMENT: LONGITUDINAL RESULTS FROM THE CHAMPION TRIAL | Journal of the American College of Cardiology IMPACT OF INTRODUCTION OF PULMONARY ARTERY PRESSURE MONITORING FOR HEART FAILURE MANAGEMENT: LONGITUDINAL RESULTS FROM THE CHAMPION TRIAL | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/3ab4f410-9d27-4297-8789-3dd49c1c458a/s0735-1097(14)60766-x.fp.png)
IMPACT OF INTRODUCTION OF PULMONARY ARTERY PRESSURE MONITORING FOR HEART FAILURE MANAGEMENT: LONGITUDINAL RESULTS FROM THE CHAMPION TRIAL | Journal of the American College of Cardiology
![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/94608269-0b33-470f-8df1-58642adc919a/gr2.jpg)
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
![Pro Position: The Data - Phoenix and Meta-Analysis of the Champion Clinical Trial Program! | tctmd.com Pro Position: The Data - Phoenix and Meta-Analysis of the Champion Clinical Trial Program! | tctmd.com](https://s3.amazonaws.com/prod.tctmd.com/public/styles/large_slide_teaser/public/2013-10/122674.png?itok=f1vwIoCn)
Pro Position: The Data - Phoenix and Meta-Analysis of the Champion Clinical Trial Program! | tctmd.com
![John P Erwin III MD FACC on Twitter: John P Erwin III MD FACC on Twitter:](https://pbs.twimg.com/media/CnvFJcsUsAAlJGv.png)